Esther Moreno-Rodilla

9PUBLICATIONS
25CO-AUTHORS
Nanotoxicology, health and safetyRespiratory diseasesPharmaceutical delivery technologiesPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 19, 2026
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Marina Labella, Rafael Nuñez, Inmaculada Doña

|Mar 06, 2025
Reply to Correspondence: What Is the Next Step for Patients With Aspirin-Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?

Inmaculada Doña, Rocío Sáenz de Santa María, Esther María Moreno

|Apr 20, 2024
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings.

Miriam Sobrino-García, Francisco J Muñoz-Bellido, Esther Moreno-Rodilla

|Jul 27, 2022
Changes in Sensitization Patterns in the Last 25 Years in 619 Patients with Confirmed Diagnoses of Immediate Hypersensitivity Reactions to Beta-Lactams.

María Del Valle Campanón Toro, Esther Moreno Rodilla, Alicia Gallardo Higueras

|May 03, 2021
Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.

Laura Pedraza-Nieto, Mónica Beunza-Sola, César A Rodríguez

|Nov 10, 2020
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.

María José Torres, Axel Trautmann, Ingrid Böhm

Pageof 2

Frequent Collaborators

3 joint publications

María José Torres

2 joint publications

Inmaculada Doña

2 joint publications

Francisco J Muñoz-Bellido

2 joint publications

Ignacio Dávila